首页 | 本学科首页   官方微博 | 高级检索  
     


Somatostatin Receptor Localization of Pancreatic Endocrine Tumors
Authors:V.D. Corleto  F. Scopinaro  S. Angeletti  A. Materia  N. Basso  E. Polettini  B. Annibale  O. Schillaci  G. D’Ambra  M. Marignani  G. Gualdi  C. Bordi  E.J. Passaro  G. Delle Fave
Affiliation:(1) Department of Gastroenterology, Second Medical Clinic, Policlinico Umberto I, Via del Policlinico, University La Sapienza, 00161 Rome, Italy, IT;(2) Department of Surgery, Second Medical Clinic, Policlinico I, Via del Policlinico, University of La Sapienza, 00161 Rome, Italy, IT;(3) Department of Radiology, First Medical Clinic, Policlinico Umberto I, Via del Policlinico, University La Sapienza, 00161 Rome, Italy, IT;(4) Department of Human Pathology, University of Parma, Via Gramsci 14, 43100 Parma, Italy, IT;(5) Department of Surgery, VA Medical Center West Los Angeles, 11301 Wilshire Boulevard, Los Angeles, California 90073, U.S.A., US
Abstract:n = 39) than conventional imaging studies (MRI, n = 25; CT, n = 13); 23 of 24 patients had positive octreotide scintigraphy, 17 of 24 had positive MRI-scans, and 12 of 24 patients had positive CT scans. It was concluded that 111 In-octreotide scintigraphy combined with conventional imaging improves the preoperative localization of presumably tumorous lesions in patients with gastroenterohepatic endocrine tumors.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号